Article Details

Bolt Biotherapeutics to Present Updates for Three Preclinical Immuno-Oncology Pipeline Programs

Retrieved on: 2022-03-09 03:58:00

Tags for this article:

Click the tags to see associated articles and topics

Bolt Biotherapeutics to Present Updates for Three Preclinical Immuno-Oncology Pipeline Programs. View article details on hiswai:

Excerpt

Bolt Bio's proprietary Boltbody™ Immune-stimulating Antibody ... (ISACs) are designed to target tumor cells for elimination by the immune system.

Article found on: www.bakersfield.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up